CEO and President Najat Khan sells $78.8K in stock

What did RECURSION PHARMACEUTICALS, INC. announce?

Najat Khan, CEO and President, sold 22,408 shares of stock worth $78,822.38 under a 10b5-1 plan.

Key details

• CEO and President Najat Khan sold shares.
• The transaction involved 22,408 shares.
• Total value of the transaction was $78,822.38.
• The sale was executed under a 10b5-1 trading plan.

Why it matters

This 4 reports an insider transaction at RECURSION PHARMACEUTICALS, INC.. The likely share-price reaction reads as neutral.

More from RECURSION PHARMACEUTICALS, INC.

• 4

  Sep 2, 2026
  Director Blake Borgeson sells $100,200 of stock

All RECURSION PHARMACEUTICALS, INC. SEC filings →